482 related articles for article (PubMed ID: 31826533)
1. [Clinical characteristics and drug susceptibility test of nontuberculous mycobacterial lung disease].
Lou H; Sun Q; Gu J; Yang H; Hao XH; Xiao HP; Sha W
Zhonghua Jie He He Hu Xi Za Zhi; 2019 Dec; 42(12):901-906. PubMed ID: 31826533
[No Abstract] [Full Text] [Related]
2. Drug susceptibility testing of slowly growing non-tuberculous mycobacteria using slomyco test-system.
Litvinov V; Makarova M; Galkina K; Khachaturiants E; Krasnova M; Guntupova L; Safonova S
PLoS One; 2018; 13(9):e0203108. PubMed ID: 30222736
[TBL] [Abstract][Full Text] [Related]
3. [Distribution and drug resistance of nontuberculous
Zhang J; Su JR; Ding BC; Liu JW; Yi JL; Yang XY; Wang NH; Wang SM
Zhonghua Jie He He Hu Xi Za Zhi; 2017 Mar; 40(3):210-214. PubMed ID: 28297817
[No Abstract] [Full Text] [Related]
4. Interrelational changes in the epidemiology and clinical features of nontuberculous mycobacterial pulmonary disease and tuberculosis in a referral hospital in Japan.
Furuuchi K; Morimoto K; Yoshiyama T; Tanaka Y; Fujiwara K; Okumura M; Izumi K; Shiraishi Y; Mitarai S; Ogata H; Kurashima A; Yoshimori K; Ohta K; Goto H; Sasaki Y
Respir Med; 2019 Jun; 152():74-80. PubMed ID: 31128614
[TBL] [Abstract][Full Text] [Related]
5. [Analysis of time for diagnosis of nontuberculous mycobacterial lung disease and its associated factors in a tuberculosis-designated hospital in Shanghai].
Zheng XB; He YF; Wang L; Sun Q; Shen XN; Wu XC; Yang JH; Yao L; Cui HY; Xu B; Yu FY; Sha W
Zhonghua Jie He He Hu Xi Za Zhi; 2023 Apr; 46(4):380-387. PubMed ID: 36990702
[No Abstract] [Full Text] [Related]
6. Pulmonary Mycobacterium kansasii infection in Israel, 1999-2004: clinical features, drug susceptibility, and outcome.
Shitrit D; Baum GL; Priess R; Lavy A; Shitrit AB; Raz M; Shlomi D; Daniele B; Kramer MR
Chest; 2006 Mar; 129(3):771-6. PubMed ID: 16537880
[TBL] [Abstract][Full Text] [Related]
7. Clinical characteristics of patients with non-tuberculous mycobacterial pulmonary disease: a seven-year follow-up study conducted in a certain tertiary hospital in Beijing.
Liu Q; Du J; An H; Li X; Guo D; Li J; Gong W; Liang J
Front Cell Infect Microbiol; 2023; 13():1205225. PubMed ID: 37424783
[TBL] [Abstract][Full Text] [Related]
8. Treatment of slowly growing mycobacteria.
Philley JV; Griffith DE
Clin Chest Med; 2015 Mar; 36(1):79-90. PubMed ID: 25676521
[TBL] [Abstract][Full Text] [Related]
9. Clinical and radiological features of Mycobacterium kansasii and other NTM infections.
Matveychuk A; Fuks L; Priess R; Hahim I; Shitrit D
Respir Med; 2012 Oct; 106(10):1472-7. PubMed ID: 22850110
[TBL] [Abstract][Full Text] [Related]
10. Differences in risk factors and drug susceptibility between Mycobacterium avium and Mycobacterium intracellulare lung diseases in China.
Zhang Z; Pang Y; Wang Y; Cohen C; Zhao Y; Liu C
Int J Antimicrob Agents; 2015 May; 45(5):491-5. PubMed ID: 25795316
[TBL] [Abstract][Full Text] [Related]
11. Clinical characteristics and treatment outcomes of pleural effusions in patients with nontuberculous mycobacterial disease.
Park S; Jo KW; Lee SD; Kim WS; Shim TS
Respir Med; 2017 Dec; 133():36-41. PubMed ID: 29173447
[TBL] [Abstract][Full Text] [Related]
12. Drug resistance and pathogenic spectrum of patients coinfected with nontuberculous mycobacteria and human-immunodeficiency virus in Chengdu, China.
Wang DM; Liao Y; Li QF; Zhu M; Wu GH; Xu YH; Zhong J; Luo J; Li YJ
Chin Med J (Engl); 2019 Jun; 132(11):1293-1297. PubMed ID: 30925547
[TBL] [Abstract][Full Text] [Related]
13. Managing antibiotic resistance in nontuberculous mycobacterial pulmonary disease: challenges and new approaches.
Kwon YS; Daley CL; Koh WJ
Expert Rev Respir Med; 2019 Sep; 13(9):851-861. PubMed ID: 31256694
[No Abstract] [Full Text] [Related]
14. [Frequently Isolated Slow Growing Nontuberculous Mycobacteria from Pulmonary Samples and Evaluation of Drug Susceptibility Testing Results in a Referral Hospital in Turkey].
Ceyhan İ; Özkara Ş; Güler MZ; Dulkar G; Altınsoy R; Vezir S
Mikrobiyol Bul; 2019 Jul; 53(3):330-335. PubMed ID: 31414634
[TBL] [Abstract][Full Text] [Related]
15. Portuguese in vitro antibiotic susceptibilities favor current nontuberculous mycobacteria treatment guidelines.
Durão V; Silva A; Macedo R; Durão P; Santos-Silva A; Duarte R
Pulmonology; 2019; 25(3):162-167. PubMed ID: 30309821
[TBL] [Abstract][Full Text] [Related]
16. Clinical significance and antibiotic susceptibilities of nontuberculous mycobacteria from patients in Crete, Greece.
Gitti Z; Mantadakis E; Maraki S; Samonis G
Future Microbiol; 2011 Sep; 6(9):1099-109. PubMed ID: 21958147
[TBL] [Abstract][Full Text] [Related]
17. The performance of interferon-gamma release assay in nontuberculous mycobacterial diseases: a retrospective study in China.
Wang MS; Wang JL; Wang XF
BMC Pulm Med; 2016 Nov; 16(1):163. PubMed ID: 27887611
[TBL] [Abstract][Full Text] [Related]
18. Epidemiology of pulmonary disease due to nontuberculous mycobacteria in Southern China, 2013-2016.
Tan Y; Su B; Shu W; Cai X; Kuang S; Kuang H; Liu J; Pang Y
BMC Pulm Med; 2018 Nov; 18(1):168. PubMed ID: 30413193
[TBL] [Abstract][Full Text] [Related]
19. [Lung diseases due to opportunistic environmental Mycobacteria in patients uninfected with human immunodeficiency virus. Risk factors, clinical and diagnostic aspects and course].
Martínez Moragón E; Menéndez R; Santos M; Lorente R; Marco V
Arch Bronconeumol; 1996 Apr; 32(4):170-5. PubMed ID: 8689013
[TBL] [Abstract][Full Text] [Related]
20. Incidence, Clinical Manifestation, Treatment Outcome, and Drug Susceptibility Pattern of Nontuberculous Mycobacteria in HIV Patients in Tehran, Iran.
Feysia SG; Hasan-Nejad M; Amini S; Hamzelou G; Kazemian H; Kardan-Yamchi J; Karami-Zarandi M; Feizabadi MM
Ethiop J Health Sci; 2020 Jan; 30(1):75-84. PubMed ID: 32116435
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
